New england peptide INC:1106042 [16-047765]
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
Vivitide LLC UEI UFTCY9CFV8J3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,825
Award facts
- Contract value 100% obligated
- $3,825.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Gardner, MA 01440, USA
Award details come from SAM.gov/FPDS.
About this award
Vivitide LLC, doing business as New England Peptide, received a firm fixed-price BPA (Blanket Purchase Agreement) call award from the National Cancer Institute valued at $3,825 on July 12, 2016, with a completion date of July 30, 2016. The contract was performed in Gardner, Massachusetts, and no set-aside designation was utilized. This award represents a task order or purchase call against an existing blanket purchase agreement vehicle, reflecting the National Cancer Institute's continued engagement with Vivitide for specialized laboratory services.
Vivitide LLC is a manufacturer and provider of custom peptide synthesis, monoclonal antibodies, modified peptides, and laboratory supplies to federal agencies within the life sciences sector. The company has established a track record of supporting the Department of Health and Human Services, including the National Institutes of Health and Centers for Disease Control and Prevention, with services spanning drug discovery and preclinical development. This particular award aligns with the National Cancer Institute's mission to advance cancer research and reflects Vivitide's specialized capabilities in peptide-based research materials and biologics critical to oncology and life sciences research programs.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Vivitide LLC by National Cancer Institute (National Institutes of Health) on July 12, 2016.
How much is contract HHSN26100001 worth?
The government has obligated $3,825 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263201500050B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award